Isotoxic Intensity Modulated Radiotherapy in stage III NSCLC – A feasibility study

Cancer shared this article with you from Inoreader Isotoxic Intensity Modulated Radiotherapy in stage III NSCLC – A feasibility study Via ScienceDirect Publication: International Journal of Radiation Oncology*Biology*Physics Publication date: Available online 21 November 2020 Source: International Journal of Radiation Oncology*Biology*Physics Author(s): Kate Haslett, Neil Bayman, Kevin Franks, Nicki Groom, Susan V. Harden, Catherine Harris, Gerard Hanna, Stephen Harrow, Matthew Hatton, Paula McCloskey, Fiona McDonald, W. David Ryder, Corinne Faivre-Finn View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.